GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (XTER:PA8) » Definitions » Short Percentage of Float

Paion Ag (XTER:PA8) Short Percentage of Float


View and export this data going back to 2005. Start your Free Trial

What is Paion Ag Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Paion Ag's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paion Ag's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Paion Ag's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Paion Ag's Short Percentage of Float falls into.


Paion Ag (XTER:PA8) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (XTER:PA8) » Definitions » Short Percentage of Float
Comparable Companies
FRA:SPB HAM:GWK3 STU:DWB FRA:BBI HAM:TLG ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB BOM:500124 BOM:532321
Traded in Other Exchanges
PAIOF:USA PA8:Germany
Address
Heussstrasse 25, Aachen, DEU, 52078
Website
https://www.paion.com
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Executives
Gregor Siebert Board of Directors
Dr. James Neil Phillips Board of Directors

Paion Ag (XTER:PA8) Headlines

No Headlines